Related Experiment Video
Updated: Jun 13, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
[Systemic lupus erythematosus].
Dusanka Martinović Kaliterna1, Mislav Radić, Ilza Salamunić
1Odsjek za klinicku imunologiju i reumatologiju, Klinika za unutarnje bolesti, Klinicki bolnicki centar Split, Soltanska 1, 21000 Split.
Systemic lupus erythematosus (SLE) is a chronic inflammatory disease affecting connective tissues, primarily in young women. Diagnosis relies on clinical and serological markers, with treatment involving corticosteroids and other immunosuppressants for severe cases.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Context:
- Systemic lupus erythematosus (SLE) is a chronic, multisystem inflammatory disease of unknown etiology.
- It predominantly affects young women and can impact joints, kidneys, serous membranes, and blood vessels.
Purpose:
- To outline the diagnostic criteria for SLE.
- To describe the management strategies for severe, active SLE.
Summary:
- Diagnosis of SLE necessitates meeting specific clinical and serological criteria.
- Management of severe active SLE typically involves corticosteroids, hydroxychloroquine, and potentially immunosuppressants.
Impact:
- Provides a concise overview of SLE diagnosis and treatment.
- Highlights key considerations for clinicians managing patients with SLE.
- Emphasizes the chronic and potentially severe nature of the disease.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Nephrotic Syndrome II : Assessment and Medical Management
Hypersensitivity Reactions: Immune-Complex Reactions
Multiple Sclerosis l: Introduction
Nephrotic Syndrome III : Nursing Management